TherapeuticsMD Cash Flow - Annual (NASDAQ:TXMD)

Add to My Stocks
$6.22 $0.1 (1.63%) TXMD stock closing price Sep 19, 2018 (Closing)

For analyzing any company like TherapeuticsMD from an investment perspective, its important to check the cash flow statement. In simple terms, the cash flow statement measures the cash that has come into the company, and the cash that has gone out during a given period, while the other statements, the income statement and balance sheet, give details about TherapeuticsMD profits and TherapeuticsMD debt. TherapeuticsMD cash flow analysis is possible because this statement breaks down how balance sheet accounts and income statement items affect cash and cash equivalents. TherapeuticsMD had cash and cash equivalents of $131.53M at the beginning of the year and $127.13M at year end for 2017. TherapeuticsMD saw a outflow of $-0.82M from investing activities for 2017.

View details of TherapeuticsMD cash flows for latest & last 10 financial years
show more
Quarterly
Annual
View Previous Years
View Next Years
Fiscal year is Jan - Dec2017201620152014201320122011
Net Income Cash Flow
-76.92M-89.87M-85.07M-54.21M-28.41M-35.12M-12.91M
Depreciation Depletion Amortization Cash-Flow----2.61M1.66M-
Net Increase (Decrease) in Assets Liabilities-6.33M--1.24M3.41M1.2M1.4M-
Cash From (used in) Discontinued Operations-------
Other Adjustments Net6.89M19.93M7.21M4.96M3.83M19.31M7.41M
Net Cash from (used by) Operating Activities
-76.15M-69.14M-79.04M-45.52M-20.76M-12.73M-4.96M
Increase (Decrease) in Prop Plant And Equipment-0.06M-0.39M-0.16M-0.03M-0.04M-0.06M-0.02M
Acquisition Disposition of Subsidiaires-------
Increase (Decrease) in Investments-------
Other Cash Inflow (Outflow) from Investment Activities-0.76M-0.85M-0.41M-0.57M-0.54M-0.2M-0.01M
Net Cash from (used by) Investment Activities
-0.82M-1.25M-0.58M-0.6M-0.58M-0.27M-0.03M
Issuance (Purchase) of Equity Shares72.58M137.22M92.97M43.29M78.68M8.08M1.72M
Issuance (Repayment) of Debt Securities-----4.69M6.55M3.08M
Increase (Decrease) in Bank & Other Borrowings------0.2M-0.1M
Payment of Dividends & Other Cash Distributions-------
Other Cash from (used by) Financing Activities-------
Net Cash from (used by) Financing Activities
72.58M137.22M92.97M43.29M73.98M14.43M4.7M
Effect of Exchange Rate Changes on Cash-------
Net Change in Cash & Cash Equivalents
-4.39M66.82M13.34M-2.82M52.63M1.42M-0.29M
Cash & Equivalents at Beginning of Year131.53M64.7M51.36M54.19M1.55M--
Cash & Equivalents at Year End127.13M131.53M64.7M51.36M54.19M1.55M-
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

TherapeuticsMD stock price history provides insight into historical stock price fluctuations, and TherapeuticsMD stock comparison chart enables peer comparison. Some of the key terms used in the statement of cash flows are:

  • Net Change in Cash and Cash Equivalents: A positive net change in cash and cash equivalents shows that TherapeuticsMD is able to meet its expenditure and grow cash at hand which demonstrates the financial strength of the company's balance sheet. Also see - TherapeuticsMD stock price movement.
  • Cash Flow from operating activities: Operating activities include the core business activities. This line item refers to the cash generated from the same and stood at a negative value of $-76.15M for TXMD.
  • Cash Flow from investment activities: TherapeuticsMD used $-0.82M cash due to investment activities. It includes the use of cash outside of normal day to day activities like buying fixed assets, plant and machinery etc.
  • Cash flow from financing activities shows the flow of cash between TherapeuticsMD and its owners and creditors and was $72.58M for 2017. Financing activities allow a company to raise capital, and repay bondholders.

Key Financial Ratios For TherapeuticsMD Cash Flow

Annual Cash Flow Statements For TherapeuticsMD Inc Peers

Juniper Pharma cash flow, Novo Nordisk cash flow, Pfizer cash flow, Theravance Biopharma cash flow